Last Updated: Friday, July 24, 2015, 22:56
A day after announcing its biggest acquisition deal of USD 880 million, Lupin Friday said it will buy Germany-based Temmler Pharma's specialty product portfolio.
Last Updated: Friday, July 24, 2015, 21:43
Standalone net profit at Rs 6,318 crore, or Rs 19.5 per share, in April-June was 11.8 percent higher than Rs 5,649 crore, or Rs 17.5 a share, in the same period a year ago.
more videos >>
